InvestorsHub Logo

Hunchbackgeek

01/08/19 7:02 PM

#39021 RE: jp68 #39019

"Based on preliminary (unaudited) results, the Company anticipates revenues for Q2 2019 of between $50 million and $55 million (net of excise taxes), compared to $11.7 million for the same quarter in the prior year, and compared to $29.7 million for the previous quarter ended September 30, 2018 ("Q1 2019"). The results reflect an anticipated revenue growth rate in excess of 327% compared to Q2 2018 and in excess of 68% compared to Q1 2019." https://ih.advfn.com/stock-market/TSX/ACB/stock-news/79010408/aurora-cannabis-provides-guidance-for-the-second-q

player1234

01/09/19 7:10 AM

#39042 RE: jp68 #39019

That number is a Price/Earnings ratio estimate (P/E)

Until they have overall positive "earnings" from continuing operations, people generally use a different metric. Often that metric is Price/Sales which can be computed using the following formula:

Market cap / total annual sales


Using the P/S ratio, ACB is priced very high (about 16).

For comparison:
PFE P/S = 4.9 TTM (Trailing Twelve Months)
PFE P/E = 11 TTM

TheBrit69

01/09/19 11:32 AM

#39072 RE: jp68 #39019

ok thanks, I wasn't sure of the multiplier number and was guessing a little. Appreciate the clarification.